Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pain, Intractable × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 30 Neoplasms 10 Pain, Postoperative 9 Lung Neoplasms 9 Colorectal Neoplasms 9 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 7 Stomach Neoplasms 6 Prostatic Neoplasms 5 Melanoma 5 Ovarian Neoplasms 4 Leiomyoma 4 Hemorrhage 4 Glioblastoma 4 Colonic Neoplasms 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myoma 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Head and Neck Neoplasms 3 Fatigue 3 Delirium 3 Chronic Pain 3 Agnosia 3 Uterine Cervical Neoplasms 2

Interventions

Ketamine 3 resiniferatoxin 2 Morphine 2 Methadone 2 Dexmedetomidine 2 ziconotide 1 substance P-saporin 1 Standard of Care 1 Sodium Chloride 1 Ropivacaine 1 Pregabalin 1 Passive Cutaneous Anaphylaxis 1 Midazolam 1 Lidocaine 1 Infusion Pumps, Implantable 1 Hydromorphone 1 Fentanyl 1 Calcium Dobesilate 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01951911 2017-07-11

KETA-1

Haukeland University Hospital

Phase 3 Withdrawn

Agnosia, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡